American Vanguard (NYSE:AVD) Bolsa

American Vanguard

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard Corp

Avantis International Equity ETF

Avadel Pharmaceuticals plc - Ordinary Share

Avadel Pharmaceuticals PLC

American Century ETF Trust Avantis International Small Cap Equity ETF

Avantis International Small Cap Value ETF

ADVENT AWI HLDGS INC ORD by Advent AWI Hldgs Inc

Advent-AWI Holdings Inc

AvidXchange Holdings, Inc. - Common Stock

AvidXchange Holdings Inc

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.03) by 900 percent. This is a 600 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $115.80 million which missed the analyst consensus estimate of $127.00 million by 8.82 percent. This is a 14.31 percent decrease over sales of $135.14 million the same period last year.

Earnings

Earnings Misses

News

American Vanguard Q1 EPS $(0.30), Sales $115.80M Miss $127.00M Estimate

American Vanguard Gets NYSE Notice Regarding Delayed 10-K Filing

Guidance

American Vanguard Corporation Sees FY25 Revenues Between $565M-$585M Vs. $585M Estimate

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly sales of $169.000 million which missed the analyst consensus estimate of $170.000 million by 0.59 percent. This is a 1.85 percent decrease over sales of $172.180 million the same period last year.

American Vanguard Q4 Sales $169.000M Miss $170.000M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Hudson Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>) is projected to report quarterly loss at $0.06 per share on revenue of $37.17 million. 
• American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $170.00 million. 
• WideOpenWest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOW#NYSE">WOW</a>) is likely to report quarterly loss at $0.13 per share on revenue of $154.05 million. 
• Buckle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKE#NYSE">BKE</a>) is expected to report quarterly earnings at $1.44 per share on revenue of $379.14 million. 
• Emerald Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $108.05 million. 
• AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $38.99 million. 
• RLX Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) is projected to report earnings for its fourth quarter. 
• Li Auto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) is expected to report earnings for its fourth quarter. 
• MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $726.90 million. 
• Bit Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) is projected to report quarterly loss at $0.03 per share on revenue of $24.76 million. 
• DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) is estimated to report earnings for its fourth quarter. 
• WeRide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) is likely to report earnings for its fourth quarter. 
• Gogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $97.80 million. 
• Tuniu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOUR#NASDAQ">TOUR</a>) is likely to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Creative Realities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREX#NASDAQ">CREX</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $16.53 million. 
• FutureFuel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) is estimated to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

BTBT

CREX

DOYU

GOGO

HSON

TOUR

Earnings Scheduled For March 14, 2025

Well-positioned to further accelerate transforming the global Company into an efficient, profitable, customer-centric organization
American Vanguard&#xAE; Corporation (AVD), a leading manufacturer and marketer of innovative solutions for the ag industry in the areas of crop protection and nutrition, turf and ornamental management, and commercial pest control (the "Company"), today announced the appointment of Douglas A. ("Dak") Kaye, III as the new Chief Executive Officer following a unanimous vote from its Board of Directors (the "Board"), effective December 9, 2024. Mr. Kaye will be based at global headquarters beginning January 6, 2025. Mr. Kaye brings extensive experience to AVD and is expected to lead the Company into a new era of growth and innovation. He will succeed the Office of CEO (OCEO), which has been in place since July 15, 2024.

Management

American Vanguard Appoints Douglas A. ("Dak") Kaye, III As Chief Executive Officer, Effective December 9, 2024

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly sales of $118.31 million which missed the analyst consensus estimate of $139.20 million by 15.01 percent. This is a 20.87 percent decrease over sales of $149.52 million the same period last year.

American Vanguard Q3 2024 Sales $118.31M Miss $139.20M Estimate

American Vanguard Reiterates Full Year 2024 Revenue (Down 2% To Flat, Excluding Product Recall Charge) And Adjusted EBITDA ($40M - $50M) Targets

American Vanguard Says Board Is Actively Engaged In Recruiting CEO To Build Upon Transformation Momentum

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.10) by 820 percent. This is a 9100 percent decrease over losses of $(0.01) per share from the same period last year.

American Vanguard Q3 2024 GAAP EPS $(0.92) May Not Be Comparable To $(0.10) Estimate

Product Was Suspended by EPA Based on One Rodent Study
American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) today announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, the Company has submitted to the Environmental Protection Agency ("EPA") voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6, 2024.
In connection with its action, the Company made the following statements.
While the Company continues to question EPA's conclusions in support of the suspension, we believe that the best course of action is to voluntarily cancel registrations of this product. We are working apace with both state and federal authorities to effect product return and to remove Dacthal from channels of distribution. It is the Company's position that product stewardship be international in scope; thus, we will now proceed to voluntarily cancel all international registrations as well.

American Vanguard Has Submitted To The EPA Voluntary Cancellation Requests For All Of Its Federal Registrations Of  Dacthal Herbicide Products

WIIM

American Vanguard shares are trading lower after the company reported worse-than-expected Q2 financial results.

Shares of Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) rose sharply in today's pre-market trading reported better-than-expected first-quarter financial results and issued <a href="https://www.benzinga.com/news/earnings/24/08/40269788/doximity-stock-soars-on-q1-earnings-the-details">strong FY24 revenue guidance.</a>
Doximity's first-quarter revenue increased 17% year-over-year to $126.68 million, beating the consensus estimate of $119.92 million, according to Benzinga Pro. The company reported adjusted earnings of 28 cents per share, beating analyst estimates of 22 cents per share.
Doximity shares jumped 28.6% to $33.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) rose 61.7% to $6.92 in today's pre-market trading after the company agreed to be acquired by Almaviva for $335 million.</li>
<li>FSD Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUGE#NASDAQ">HUGE</a>) gained 53% to $0.14 in pre-market trading after gaining 16% on Thursday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 45.8% to $2.80 in pre-market trading. Nauticus Robotics partnered with Florida Atlantic University for cost-effective Aquanaut Mark 2 testing.</li>
<li>Avinger, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares rose 28.3% to $1.54 in pre-market trading after reporting second-quarter results.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) gained 27.7% to $10.14 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued Q3 product revenue guidance above estimates.</li>
<li>Clearmind Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) shares gained 27.7% to $1.52 in pre-market trading after declining around 8% on Thursday.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) gained 27.1% to $2.30 in pre-market trading after the company announced AI-powered tool enhancements to its integrations with Reddit and X.</li>
<li>Babcock &amp; Wilcox Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) gained 22.5% to $1.36 following second-quarter results.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) jumped 22.3% to $32.11 in pre-market trading after the company reported better-than-expected second-quarter revenue results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) shares dipped 30.8% to $5.66 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>PubMatic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>) shares declined 26.4% to $14.40 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>Cutera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ">CUTR</a>) shares declined 21.4% to $0.88 in pre-market trading after the company reported worse-than-expected second-quarter revenue results and cut its FY24 revenue guidance below estimates.</li>
<li>Nerdy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) declined 20.1% to $1.27 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>FiscalNote Holdings, Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) shares fell 18.3% to $1.12 in pre-market trading after reporting second-quarter results.</li>
<li>Eventbrite, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) fell 17.1% to $3.15 in today's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued FY24 revenue guidance below estimates.</li>
<li>AMMO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) shares fell 16.7% to $1.35 in pre-market trading after the company reported weak first-quarter sales.</li>
<li>Five9, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) fell 16.4% to $35.49 in pre-market trading after the company posted second-quarter results.</li>
<li>Trevena, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) fell 14.7% to $0.19 pre-market trading after the company reported second-quarter results.</li>
<li>Anew Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WENA#NASDAQ">WENA</a>) shares fell 10.1% to $1.15 in pre-market trading after gaining 17% on Thursday.</li>
</ul>
Now Read This: &lt;a href=&#8221;https://www.benzinga.com/news/earnings/24/04/38307448/investor-sentiment-decreases-further-s-p-500-falls-for-fourth-straight-session&#8221;&gt;&lt;em&gt; Investor Sentiment Decreases Further, S&amp;P 500 Falls For Fourth Straight Session&lt;/em&gt;&lt;/a&gt;

Pre-Market Outlook

Markets

Movers

Trading Ideas

AVGR

CMND

CUTR

DOCS

FIVN

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

IOVA

KITT

MRIN

NOTE

NRDY

POWW

PUBM

TRVN

WENA

Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.01) by 4100 percent. This is a 950 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $128.21 million which missed the analyst consensus estimate of $139.00 million by 7.76 percent. This is a 3.45 percent decrease over sales of $132.79 million the same period last year.

American Vanguard Q2 EPS $(0.42) Misses $(0.01) Estimate, Sales $128.21M Miss $139.00M Estimate

Lake Street analyst Ben Klieve initiates coverage on American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) with a Buy rating and announces Price Target of $14.

Price Target

Initiation

Analyst Ratings

Lake Street Initiates Coverage On American Vanguard with Buy Rating, Announces Price Target of $14

American Vanguard Reports CEO Eric G. Wintemute Steps Down, Effective July 12, 2024; Will Continue As Chairman And Provide Consulting Services Part-Time Per Transition Agreement Dated July 3, 2024

American Vanguard Chairman And CEO Eric Wintemute To Retire As CEO

American Vanguard Executive Vice President & COO Bob Trogele To Retire, Effective May 31, 2024

American Vanguard shares are trading lower after the company reported worse-than-expected Q1 financial results.

Shares of Diodes Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIOD#NASDAQ">DIOD</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/DIOD/earnings">quarterly financial results</a>.
Diodes posted adjusted earnings of 28 cents per share, missing market estimates of 31 cents per share. The company's quarterly sales came in at $301.97 million missing expectations of $305.01 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Diodes shares dipped 9.8% to $68.99 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares jumped 139% to $10.73 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.</li>
<li>iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) gained 40% to $17.06 after the company announced a $120 million registered direct offering and reported Q1 financial results.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares climbed 39.8% to $1.65 after the company disclosed a partnership with LITEON Technology Corporation.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) shares climbed 39.4% to $32.86 after the company reported better-than-expected first-quarter sales results.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) gained 34.3% to $13.90 after the company reported better-than-expected first-quarter financial results.</li>
<li>Organogenesis Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>) rose 32% to $3.02 following upbeat quarterly results.</li>
<li>Inseego Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) gained 31.4% to $5.05 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.</li>
<li>CareDx, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) surged 26.3% to $13.99 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Sensus Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) shares rose 22.5% to $4.6699 after the company reported better-than-expected first-quarter financial results.</li>
<li>Groupon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) gained 22.3% to $12.85 after the company reported better-than-expected first-quarter results.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) jumped 21.8% to $1.90 after the company reported better-than-expected quarterly GAAP EPS results.</li>
<li>ADMA Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) rose 21% to $8.39 after the company reported better-than-expected first-quarter financial results and issued strong revenue guidance.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares gained 19.3% to $5.66 in pre-market trading after the company reported better-than-expected first quarter financial results.</li>
<li>American Coastal Insurance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) rose 17.2% to $12.79 after the company reported better-than-expected first quarter financial results. The company announced the sale of 100% of its issued and outstanding stock of Interboro Insurance Company to Forza Insurance Holdings.</li>
<li>Global Gas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGAS#NASDAQ">HGAS</a>) rose 15.3% to $1.28.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) gained 15% to $23.42 after the company reported better-than-expected quarterly earnings and authorized a $3 billion share repurchase program.</li>
<li>Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) gained 14.6% to $1,478.49 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) rose 14.4% to $7.61.</li>
<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) climbed 13.6% to $2.74 following upbeat quarterly results.</li>
<li>Natural Grocers by Vitamin Cottage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGVC#NASDAQ">NGVC</a>) gained 13.2% to $20.19 following second-quarter results.</li>
<li>Natera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) rose 11.3% to $106.36 following strong first-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) jumped 11% to $6.50 following first-quarter results.</li>
<li>Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) gained 8.8% to $9.12 after the company reported better-than-expected first-quarter sales results and issued FY24 revenue guidance above estimates.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) jumped 8.7% to $35.68 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $33 to $46.</li>
<li>Funko Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) gained 7% to $7.30 as the company reported better-than-expected first-quarter earnings and issued strong earnings forecast for the second quarter. The company also appointed Cynthia Williams as its Chief Executive Officer, effective May 20.</li>
<li>Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) gained 6.8% to $34.26 after the company reported better-than-expected first-quarter financial results and raised its FY24 EPS range.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) shares rose 3.5% to $12.94 after the company reported stronger-than-expected financial results for the first quarter on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) shares fell 73.4% to $3.9089 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) fell 37.2% to $0.0439 after jumping 20% on Thursday.</li>
<li>Flux Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) dipped 35.8% to $2.9350 after the company reported worse-than-expected quarterly financial results.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) fell 29.3% to $1.30 after the company announced second half and full year 2023 financial results.</li>
<li>Evolv Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) fell 29.2% to $2.7290 after the company reported worse-than-expected first-quarter financial results and lowered its FY24 sales guidance below estimates.</li>
<li>Revance Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) fell 27% to $3.0950 as the company posted a loss for its first quarter on Thursday.</li>
<li>Biofrontera Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) fell 26.6% to $1.16.</li>
<li>American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) dipped 22.2% to $9.84 following weak quarterly results.</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) dipped 22% to $0.25.</li>
<li>The Beauty Health Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) fell 22% to $2.80 following quarterly results.</li>
<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares fell 21.6% to $1.27 after the company reported worse-than-expected first-quarter GAAP EPS results.</li>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) shares fell 21.5% to $25.51 after the company reported worse-than-expected first-quarter sales results and issued FY24 sales guidance below estimates.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares declined 20.7% to $0.0579 after the company reported worse-than-expected first quarter financial results.</li>
<li>The E.W. Scripps Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) dipped 19.7% to $3.71 following quarterly results.</li>
<li>CS Disco, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAW#NYSE">LAW</a>) fell 19.6% to $6.50 following weak sales.</li>
<li>Safe and Green Development Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGD#NASDAQ">SGD</a>) shares fell 18.4% to $0.6937 after jumping around 37% on Thursday.</li>
<li>Docebo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) fell 18.2% to $37.99.</li>
<li>JFrog Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares fell 17.7% to $33.43 after the company reported first quarter financial results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) shares fell 17.3% to $0.7606 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) fell 15.6% to $11.35 following first-quarter financial results.</li>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares declined 14.4% to $0.8320 after the company reported worse-than-expected first quarter GAAP EPS results.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares fell 12.8% to $4.0850 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) declined 12.2% to $14.72.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) fell 11.1% to $21.97 after the company reported second-quarter financial results.</li>
<li>AMN Healthcare Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMN#NYSE">AMN</a>) fell 9.5% to $55.08 following first-quarter results.</li>
<li>Evolent Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) fell 8.4% to $24.69 after the company reported first-quarter financial results.</li>
<li>Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) fell 8.1% to $94.16 after the company issued weak guidance.</li>
<li>Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) declined 7.8% to $17.28 following second-quarter financial results.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) dipped 7.4% to $3.3399.</li>
<li>MoonLake Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) fell 7% to $39.02.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) fell 5% to $33.13. BMO Capital analyst James Fotheringham maintained Affirm with a Market Perform and lowered the price target from $48 to $46.</li>
<li>Runway Growth Finance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWAY#NASDAQ">RWAY</a>) shares fell 4.1% to $11.61 as the company priced its secondary offering of 3.75 million common stock by selling stockholder at $11.50 per share.</li>
<li>Yelp Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) shares declined 3.6% to $38.20 after the company reported a first-quarter revenue miss.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38760794/bitcoin-tops-63-000-akash-network-emerges-as-top-gainer">Bitcoin Tops $63,000; Akash Network Emerges As Top Gainer</a>

Intraday Update

ACIC

ADMA

AEHL

AFRM

AKAM

ARRY

ARWR

BFRI

BROS

CDNA

CLNE

DCBO

DIOD

EVLV

FLNC

FLUX

FNKO

FROG

FWRD

GRPN

GRTS

GWAV

HGAS

INSG

ITOS

LIDR

MGNX

MLTX

MVIS

NGVC

NTRA

NVAX

NVTS

ORGO

OUST

PEGY

PGNY

RVNC

RWAY

SKIN

SKYT

SOUN

SRTS

YELP

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Press Releases

American Vanguard Appoints Industry Veteran, Douglas A. ("Dak") Kaye, III as Chief Executive Officer

American Vanguard Announces Changes to Its Board

American Vanguard CEO Dak Kaye to be Featured in Lake Street Capital Investor Forum

AMVAC®, DPH Biologicals™ Sign Regional Distribution Agreement

American Vanguard Announces Date of Fourth Quarter 2024 Earnings Release and Webcast Conference Call

Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025

American Vanguard Reports Preliminary Results for Fourth Quarter & Full Year 2024

Comments

American Vanguard

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL